Sign in
TerminatedPhase 2

Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging

Key facts

Who runs it
University of Maryland, Baltimore
Where
Baltimore, United StatesSee the site
Trial code
Status
Terminated
Phase
Phase 2
People taking part
4 people enrolled
Started
1 Dec 2020
Ended
5 Dec 2025
Type of study
Interventional
Treatments tested
  • Hyperpolarized 13C-Pyruvate
Record updated
15 July 2026
Why it stopped
"Study terminated due to institutional resource constraints, including limited availability of specialized equipment and technical support. Termination was not related to participant safety, data quality, study conduct, or the investigational product

Who can take part

Age
40 years to 80 years
Sex
Men only
Healthy volunteers
Cannot take part
Show the full registry criteria (5)Hide the full registry criteria

Who can take part

  • Age greater than 40 and less than 80 years
  • Clinical suspicion or history of prostate cancer reflected by one of the following:; PSA > 4ng/ml; Abnormal DRE exam; Known tissue diagnosis of prostate cancer from prior workup
  • Patient planning to undergo either a MRI targeted biopsy or radical prostatectomy for prostate cancer workup or treatment

Who cannot take part

  • Inability to undergo MRI scan
  • Inability to receive IV contrast as per institutional protocol

Where in United States

  • University of Maryland Medical CenterBaltimore, United States

About the trial

What the trial wants to find out

This is a two-tiered pilot study in which there will be no randomization and no placebo treatment. This study will be to perform metabolic magnetic resonance imaging on men suspected to have a prostate cancer to understand if metabolic MRI can be safely performed on this population

The group in the trial

  • Single-arm study in patients who are suspected or known to have prostate cancerTreatment being tested

    Perform metabolic magnetic resonance imaging on men suspected to have a prostate cancer to understand if metabolic MRI can be safely performed on this population

    Treatment: Hyperpolarized 13C-Pyruvate

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging in the Diagnosis and Risk-Stratification of Prostate Cancer
Record updated
15 July 2026